Skip to content

Envoy Medical COCH Other Income - Net

Other Income - Net at other companies

Agrify Corporation logo
Agrify CorporationRYM
-$1.64M-483%
Taylor Devices logo
Taylor DevicesTAYD
$351.45K-2.5%
ePlus logo
ePlusPLUS
$0-100%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$4.61M+12.9%
Bit Digital logo
Bit DigitalBTBT
-$6.94M-48.7%
CO2 Energy Transition Corp. Common Stock logo
CO2 Energy Transition Corp. Common StockNOEM
$632.15K-12.6%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's other income - net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's other income - net?
Envoy Medical (COCH) reported other income - net of $1.61M in Q1 2026.
How has Envoy Medical's other income - net changed year-over-year?
Envoy Medical's other income - net increased by 1375.2% year-over-year, from $109K to $1.61M.
What does other income - net mean?
Aggregates income or expenses derived from activities outside the company's primary business operations, such as investment returns, foreign exchange gains, or miscellaneous non-core items. It serves as a measure of peripheral financial performance that is independent of the company's main revenue-generating activities. Investors use this to isolate core operating profitability from incidental financial events.